Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Else

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Pancreas|May 3, 2021
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and ParagangliomaLauren Fishbein, Jaydira Del Rivero, Tobias Else, et al.
The New England Journal of Medicine|October 22, 2025
Belzutifan for Advanced Pheochromocytoma or ParagangliomaCamilo Jimenez, Mikkel Andreassen, Alice Durand, et al.
Cancer Cell|February 7, 2017
Comprehensive Molecular Characterization of Pheochromocytoma and ParagangliomaLauren Fishbein, Ignaty Leshchiner, Vonn Walter, et al.
Journal of the National Cancer Institute|March 11, 2026
Quality of life and care experiences in a US multi-institutional neuroendocrine tumor cohortMichael A O'Rorke, Tao Xu, Rhonda R Decook, et al.
Nature Communications|March 18, 2025
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Research Square|July 9, 2024
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Cancer Research|May 2, 2023
β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal CancerDipika R Mohan, Kleiton S Borges, Isabella Finco, et al.
Journal of Clinical and Translational Science|March 13, 2026
Using a participation monitoring database to enhance recruitment in a rare cancer populationMichael A O'Rorke, Brian M Gryzlak, Tao Xu, et al.
Endocrine|April 27, 2026
Assessing Patient Characteristics in Neuroendocrine Tumor Research: A Comparison of the NET-PRO Study to SEER Population-Based DataMichael A O'Rorke, Bradley D McDowell, Tao Xu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2020
Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year UpdateGustavo Armaiz-Pena, Shahida K Flores, Zi-Ming Cheng, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Pancreas|May 3, 2021
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and ParagangliomaLauren Fishbein, Jaydira Del Rivero, Tobias Else, et al.
The New England Journal of Medicine|October 22, 2025
Belzutifan for Advanced Pheochromocytoma or ParagangliomaCamilo Jimenez, Mikkel Andreassen, Alice Durand, et al.
Cancer Cell|February 7, 2017
Comprehensive Molecular Characterization of Pheochromocytoma and ParagangliomaLauren Fishbein, Ignaty Leshchiner, Vonn Walter, et al.
Journal of the National Cancer Institute|March 11, 2026
Quality of life and care experiences in a US multi-institutional neuroendocrine tumor cohortMichael A O'Rorke, Tao Xu, Rhonda R Decook, et al.
Nature Communications|March 18, 2025
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Research Square|July 9, 2024
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Cancer Research|May 2, 2023
β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal CancerDipika R Mohan, Kleiton S Borges, Isabella Finco, et al.
Journal of Clinical and Translational Science|March 13, 2026
Using a participation monitoring database to enhance recruitment in a rare cancer populationMichael A O'Rorke, Brian M Gryzlak, Tao Xu, et al.
Endocrine|April 27, 2026
Assessing Patient Characteristics in Neuroendocrine Tumor Research: A Comparison of the NET-PRO Study to SEER Population-Based DataMichael A O'Rorke, Bradley D McDowell, Tao Xu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2020
Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year UpdateGustavo Armaiz-Pena, Shahida K Flores, Zi-Ming Cheng, et al.
Pageof 14